Table 2.

Network meta-analysis results of the mean difference in HbA1c (left lower half) and body weight (right upper half) in patients with the following interventions: ORS=Oral semaglutide, SUS=Subcutaneous semaglutide, GLP = GLP-1 RA comparator, and PLC=Placebo.

Network comparison, HbA1c and body weight
SUS	−1.08 (−2.04, −0.12)	−3.64 (−4.42, −2.86)	−4.25 (−5.06, −3.43)
−0.26 (−0.44, −0.07)	ORS	−2.56 (−3.41, −1.71)	−3.17 (−3.89, −2.45)
−0.57 (−0.72, −0.43)	−0.32 (−0.49, −0.15)	GLP	−0.61 (−1.43, 0.21)
−1.56 (−1.71, −1.40)	−1.30 (−1.44, −1.16)	−0.98 (−1.15, −0.82)	PLC